Academic journals

Analysis and Comment (8)

9sz6nvvg-1369098854
It’s time to let the journal impact factor die. Ben McLeod

Do not resuscitate: the journal impact factor declared dead

By Brendan Crabb, Burnet Institute

Science is a highly competitive business so measuring the impact of scientific research, meaningfully and objectively, is essential. The journal impact factor (JIF) has emerged over the past few decades…
33v79kd6-1349409275
It’s easy to put open-access publishing on a pedestal, but it’s important to consider the ramifications first. smileham

Open-access science: be careful what you wish for

By Geraint Lewis

In recent weeks we’ve seen a renewed push to introduce open access to science research publications. The concept is simple: research that is paid for by public funds should be made freely available, not…
87bwp28x-1349224206
Open-access journals are gaining credibility and prestige. rvm_71

Open access will change the world, if scientists want it to

By Terry Sunderland, Centre for International Forestry Research

While the Australian Research Council considers its policy on open-access publication and others within the scientific community call for the increased sharing of scientific data, the British are already…
2mdbkpqv-1344912360
The pressure on academics is becoming too much, there needs to be cultural change. Stressed image from www.shutterstock.com

Cracks in the ivory tower: is academia’s culture sustainable?

By Euan Ritchie, Deakin University and Joern Fischer, Leuphana University

The pressure is on. More and more universities and academics are working in a culture that is untenable and cracks in the ivory tower have already begun to appear. The work environment is now characterised…
Z3s7848r-1336018424
Academic publishing firms have been all too keen to monopolise a crucial public good: academic knowledge. giulia.forsythe

The great publishing swindle: the high price of academic knowledge

By Philip Soos, Deakin University

One of the great outrages of academia in the modern age is the privatisation of the profits accruing to publicly-financed knowledge. One form is that of academic journals, a primary method of disseminating…
8wcz3tgv-1333342919
Vioxx is the quintessential story of what can go wrong when a big pharmaceutical company exerts influence over the evidence base. AAP

Pharma’s influence over published clinical evidence

By Adam Dunn

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Bfwhb5vr-1333342223
Acknowledging that things don’t always go right, and trying to figure out what went wrong are hallmarks of a transparent and mature profession. AAP

Clearing the air: why more retractions are good for science

By Ivan Oransky, New York University

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…

Participants (40)